Clara Pereira

Dr. Clara Pereira

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2007 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
Clara PereiraClara Pereira
Clara Pereira
NCNadine Camougrand
Nadine Camougrand
Stéphen MANONStéphen MANON
Stéphen MANON
MSMaria João Sousa
Maria João Sousa
MCManuela Côrte-Real
Manuela Côrte-Real

1 July 2008 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
Clara PereiraClara Pereira
Clara Pereira
RSR.D. Silva
R.D. Silva
Lucília SaraivaLucília Saraiva
Lucília Saraiva
BJBjörn Johansson
Björn Johansson
MSMaria João Sousa
Maria João Sousa
MCM. Côrte-Real
M. Côrte-Real

16 March 2010 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
Clara PereiraClara Pereira
Clara Pereira
SCSusana Chaves
Susana Chaves
SASara Alves
Sara Alves
BSBénédict Salin
Bénédict Salin
NCNadine Camougrand
Nadine Camougrand
MCManuela Côrte-Real
Manuela Côrte-Real

29 November 2006 in FEBS Letters
Verified
Journal Article
Closed access
NGNicoletta Guaragnella
Nicoletta Guaragnella
Clara PereiraClara Pereira
Clara Pereira
MSMaria João Sousa
Maria João Sousa
LALucia Antonacci
Lucia Antonacci
SPSalvatore Passarella
Salvatore Passarella
Sergio GiannattasioSergio Giannattasio
Sergio Giannattasio

3 September 2014 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
Clara QuintasClara Quintas
Clara Quintas
DPDiana Pinho
Diana Pinho
Clara PereiraClara Pereira
Clara Pereira
Lucília SaraivaLucília Saraiva
Lucília Saraiva
Jorge GonçalvesJorge Gonçalves
Jorge Gonçalves
Maria da Glória Correia da Silva QueirozMaria da Glória Correia da Silva Queiroz
Maria da Glória Correia da Silva Queiroz
During cerebral inflammation uracil nucleotides leak to the extracellular medium and activate glial pyrimidine receptors contributing to the development of a reactive phenotype. Chronically activated microglia acquire an anti-inflammatory phenotype that favors neuronal differentiation, but the impact of these microglia on astrogliosis is unknown. We investigated the contribution of pyrimidine receptors to microglia-astrocyte signaling in a chronic model of inflammation and its impact on astrogliosis. Co-cultures of astrocytes and microglia were chronically treated with lipopolysaccharide (LPS) and incubated with uracil nucleotides for 48 h. The effect of nucleotides was evaluated in methyl-[3H]-thymidine incorporation. Western blot and immunofluorescence was performed to detect the expression of P2Y6 receptors and the inducible form of nitric oxide synthase (iNOS). Nitric oxide (NO) release was quantified through Griess reaction. Cell death was also investigated by the LDH assay and by the TUNEL assay or Hoechst 33258 staining. UTP, UDP (0.001 to 1 mM) or PSB 0474 (0.01 to 10 μM) inhibited cell proliferation up to 43 ± 2% (n = 10, P <0.05), an effect prevented by the selective P2Y6 receptor antagonist MRS 2578 (1 μM). UTP was rapidly metabolized into UDP, which had a longer half-life. The inhibitory effect of UDP (1 mM) was abolished by phospholipase C (PLC), protein kinase C (PKC) and nitric oxide synthase (NOS) inhibitors. Both UDP (1 mM) and PSB 0474 (10 μM) increased NO release up to 199 ± 20% (n = 4, P <0.05), an effect dependent on P2Y6 receptors-PLC-PKC pathway activation, indicating that this pathway mediates NO release. Western blot and immunocytochemistry analysis indicated that P2Y6 receptors were expressed in the cultures being mainly localized in microglia. Moreover, the expression of iNOS was mainly observed in microglia and was upregulated by UDP (1 mM) or PSB 0474 (10 μM). UDP-mediated NO release induced apoptosis in astrocytes, but not in microglia. In LPS treated co-cultures of astrocytes and microglia, UTP is rapidly converted into UDP, which activates P2Y6 receptors inducing the release of NO by microglia that causes astrocyte apoptosis, thus controlling their rate of proliferation and preventing an excessive astrogliosis.

1 June 2009 in Microbiology
Verified
Journal Article
Open access
APA. Pacheco
A. Pacheco
Clara PereiraClara Pereira
Clara Pereira
MAM. J. Almeida
M. J. Almeida
MSMaria João Sousa
Maria João Sousa
TheHSP12gene encodes one of the two major small heat-shock proteins ofSaccharomyces cerevisiaeand is induced under different conditions, such as low and high temperatures, osmotic or oxidative stress and high sugar or ethanol concentrations. However, few studies could demonstrate any correlation betweenHSP12deletion or overexpression and a phenotype of sensitivity/resistance, making it difficult to attribute a role for Hsp12p under several of these stress conditions. We investigated the possible role of Hsp12p in yeast freezing tolerance. Contrary to what would be expected, thehsp12null mutant when subjected to prolonged storage at −20 °C showed an increased resistance to freezing when compared with the isogenic wild-type strain. Because the mutant strain displayed a higher intracellular trehalose concentration than the wild-type, which could mask the effect of manipulatingHSP12, we overexpressed theHSP12gene in a trehalose-6-phosphate synthase (TPS1) null mutant. Thetps1Δ strain overexpressingHSP12showed an increase in resistance to freezing storage, indicating that Hsp12p plays a role in freezing tolerance in a way that seems to be interchangeable with trehalose. In addition, we show that overexpression ofHSP12in thistps1Δ strain also increased resistance to heat shock and that absence ofHSP12compromises the ability of yeast cells to accumulate high levels of trehalose in response to a mild heat stress.